The store will not work correctly when cookies are disabled.
2-Hydroxyethylamino-7-dimethylamino-4,5-dihydro-1H-benzo[d][1,3]diazepine
ID: ALA3977625
PubChem CID: 134151989
Max Phase: Preclinical
Molecular Formula: C13H20N4O
Molecular Weight: 248.33
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CN(C)c1ccc2c(c1)CCN=C(NCCO)N2
Standard InChI: InChI=1S/C13H20N4O/c1-17(2)11-3-4-12-10(9-11)5-6-14-13(16-12)15-7-8-18/h3-4,9,18H,5-8H2,1-2H3,(H2,14,15,16)
Standard InChI Key: DIGGXUCVDVBAGD-UHFFFAOYSA-N
Molfile:
RDKit 2D
18 19 0 0 0 0 0 0 0 0999 V2000
19.5222 -12.6779 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.3280 -12.4915 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6827 -11.7490 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.3280 -11.0064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5222 -10.8242 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8785 -11.3367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8785 -12.1614 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1629 -10.9244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4474 -11.3367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4474 -12.1614 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1629 -12.5737 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8400 -13.1398 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.6636 -13.1081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1031 -13.8059 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7334 -10.9241 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.7337 -10.0994 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0191 -11.3361 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7185 -14.5354 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 1 0
5 6 1 0
6 7 1 0
1 7 1 0
8 9 1 0
9 10 2 0
10 11 1 0
7 11 2 0
6 8 2 0
12 13 1 0
2 12 1 0
13 14 1 0
9 15 1 0
15 16 1 0
15 17 1 0
14 18 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 248.33 | Molecular Weight (Monoisotopic): 248.1637 | AlogP: 0.66 | #Rotatable Bonds: 3 |
Polar Surface Area: 59.89 | Molecular Species: BASE | HBA: 5 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 10.13 | CX LogP: 0.91 | CX LogD: -1.34 |
Aromatic Rings: 1 | Heavy Atoms: 18 | QED Weighted: 0.74 | Np Likeness Score: -0.51 |
References
1. McMullan M, García-Bea A, Miranda-Azpiazu P, Callado LF, Rozas I.. (2016) Substituted conformationally restricted guanidine derivatives: Probing the α2-adrenoceptors' binding pocket., 123 [PMID:27474922] [10.1016/j.ejmech.2016.07.011] |